Regulation of Arf6 and ACAP1 Signaling by the PTB-Domain-Containing Adaptor Protein GULP  by Ma, Zhong et al.
Current Biology 17, 722–727, April 17, 2007 ª2007 Elsevier Ltd All rights reserved DOI 10.1016/j.cub.2007.03.014Report
Regulation of Arf6 and ACAP1
Signaling by the PTB-Domain-Containing
Adaptor Protein GULPZhong Ma,1 Zhongzhen Nie,3 Ruibai Luo,3
James E. Casanova,2 and Kodi S. Ravichandran1,*
1Carter Immunology Center and
the Department of Microbiology
2Department of Cell Biology
University of Virginia
Charlottesville, Virginia 22908




TheGTPaseArf6 regulatesmultiple cellular processes,
including endocytosis, secretion, phagocytosis, cell
adhesion, and cell migration [1, 2]. The Arf6-specific
GAP ACAP1 is a negative regulator of Arf6-mediated
signaling [3–7]. However, regulation of ACAP1- and
Arf6-mediated signaling by other cellular proteins is
not well understood. GULP/CED-6 is a phosphotyro-
sine binding (PTB)-domain-containing adaptor protein
linked to engulfment of apoptotic cells [8–13] and to
cholesterol homeostasis [14]. Here, we identify a novel
role for GULP as a positive regulator of Arf6. Knock-
down of GULP decreased cellular Arf6-GTP, whereas
GULP overexpression increased cellular Arf6-GTP. At
the mechanistic level, GULP influenced Arf6 at four
levels. First, GULP bound directly to GDP-bound Arf6
via its PTB domain. Second, GULP associated with
the Arf6-GAP ACAP1 at endogenous levels. Third,
GULP reversed the Arf6-GTP decrease induced by
ACAP1, and countered the ACAP1-mediated inhibition
of cell migration. Fourth, GULP, ACAP1, and GDP-
bound Arf6 were part of a tripartite complex, suggest-
ing sequestration of ACAP1 as one mechanism of
GULP action. Taken together, these data identify
GULP as a modifier of cellular Arf6-GTP through regu-
lation of ACAP1. Because PTB-domain-containing
adaptor proteins influence endocytosis and trafficking
of membrane proteins and cell migration [15, 16], our
data support amodel wherein PTB-domain-containing
adaptor proteins regulate Arf family proteins.
Results and Discussion
Direct Binding of GULP to Arf6
Our previous studies on GULP and its potential role in
endocytosis [14] prompted us to examine a link between
GULP- and Arf6-mediated signaling. When we tested
a potential GULP:Arf6 interaction, bacterially produced
full-length GULP was able to precipitate GFP-tagged
Arf6 from cell lysates. GULP bound two mutant forms,
Arf6T27N and Arf6T44N, that preferentially bind GDP. No
detectable binding was observed toward Arf6Q67L,
*Correspondence: ravi@virginia.eduwhich is preferentially GTP bound [17] (Figure 1A).
GULP did not bind other small GTPases such as Rac1,
RhoG, or Cdc42 either in the preferentially GTP-bound
(QL mutants) or GDP-bound (TN mutants) forms (Fig-
ure 1B). GULP also precipitated endogenous Arf6 from
cell lysates (Figure 1C, lane 1).
GULP is composed of an N-terminal phosphotyrosine
binding (PTB) domain followed immediately by a leucine
zipper (LZ) domain and a C-terminal region of 100 amino
acids with no obvious domains (Figure 1D, top) [18]. The
GULP-PTB domain was able to precipitate endogenous
Arf6 (Figure 1C, lane 3). Under these conditions, the
LZ+C region of GULP or the PTB domain of another
adaptor, Shc, did not appreciably precipitate endoge-
nous Arf6 (Figure 1C). To further examine whether the
GULP:Arf6 interaction is direct, we produced recombi-
nant Arf6T27N or Arf6Q67L versions in bacteria. We first
confirmed that Arf6Q67L was GTP bound by a GST-
GGA pull-down assay, and Arf6T27N was not precipitated
by GGA (Figure S1 in the Supplemental Data available
online). Both full-length GULP and an isolated PTB
domain of GULP bound specifically to the Arf6T27N, but
not the Arf6Q67L. Thus, the binding of GULP to Arf6 oc-
curred preferentially to the GDP-bound form of Arf6. A
GULP mutant that lacks the first 24 amino acids of the
PTB domain severely impaired GULP interaction with
Arf6 (Figure 1D). These data suggested a novel interac-
tion between GULP-PTB and Arf6 and a possible role for
GULP in regulating Arf6 function.
GULP Regulates Arf6-GTP Level in Cells
We then asked whether GULP would regulate Arf6-GTP
level in cells. We knocked down GULP expression in
MEF-1 cells or LR73 cells and assessed the effect of
GULP depletion on endogenous Arf6-GTP. Compared
to control MEF-1 cells, cells depleted of endogenous
GULP showed a dramatic reduction in cellular Arf6-
GTP (as determined by GGA-mediated precipitation of
Arf6-GTP) (Figure 1E). No reduction was observed in
total Arf6 protein or a control protein, ERK2, in the
same cell lysates (Figure 1E). Similar reduction in Arf6-
GTP was also observed in LR73 cells after knockdown
of GULP. As a corollary, overexpression of full-length
GULP in LR73 cells led to increased Arf6-GTP. These
data suggested a key role for GULP in regulating endog-
enous Arf6 activation. Because Arf6 can regulate cell
migration, we assessed whether GULP-mediated regu-
lation of Arf6-GTP level would influence migration of
LR73 cells. Compared to control LR73 cells, GULP over-
expression promoted cell migration toward fibronectin,
whereas knockdown of GULP reduced cell migration
(Figure 1F).
GULP Binds the Arf6-GAP ACAP1 and Influences
Cellular Arf6-GTP Level
The effect of GULP on cellular Arf6-GTP level could be
either direct or indirect. We tested whether GULP itself
might directly promote GTP loading of Arf6. However,
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(A) GULP binds GDP-Arf6. GFP-tagged wild-type Arf6 or the mutants expressed in HeLa cells were precipitated with bacterially produced
GST-GULP and assessed for binding. Comparable expression of the Arf6 proteins in total lysates is shown (bottom).
(B) GULP binds specifically to Arf6. Q/L or T/N mutants of Arf6-HA, Flag-Rac1, Flag-RhoG, or Myc-Cdc42 were expressed in HeLa cells, and
their precipitation with GST-GULP was assessed by immunoblotting for the individual epitope-tagged GTPases.
(C) GULP interacts with endogenous Arf6. GST-tagged full-length GULP (GULP-FL), GULP-PTB, GULP-LZ+C, or the Shc-PTB domain was
incubated with MEF-2 cell lysates, and Arf6 binding was detected by immunoblotting. The GST fusion proteins were visualized by Ponceau
S staining.
(D) GULP directly binds Arf6 via the PTB domain. Schematic diagram of GULP and the mutants (top). Arf6T27N and Arf6Q67L mutants were incu-
bated with GULP (all bacterially produced), and binding was assessed by anti-Arf6 immunoblotting. GST-GULP was visualized by Ponceau S
staining. DN1-24 mutant lacks the first 24 amino acids of the GULP-PTB domain. A line indicates the lanes from the same gel that were not
run contiguously, but spliced together for presentation.
(E) Knockdown of GULP expression decreases endogenous Arf6-GTP in cells. Arf6-GTP levels in two of the GULP-knockdown MEF-1 clones and
a control clone were assessed by a GST-GGA pull-down assay. Comparable Arf6 expression in the cell lines was revealed by immunoblotting.
ERK2 immunoblotting revealed equal protein loading. Arf6-GTP levels were compared after setting the ratio of the Arf6-GTP signal to total Arf6
signal in the control clone as 1.0. Relative GULP expression was compared after setting the ratio of GULP signal to ERK2 signal in the control
clone as 1.0.
(F) Knockdown or overexpression of GULP in LR73 cells affects cellular Arf6-GTP and cellular migration. Arf6-GTP level in cells with GULP
overexpression or knockdown was assessed as in Figure 1E. Cell migration to fibronectin was done in a Transwell assay. * indicates p < 0.05
(mean 6 standard error of the mean [SEM], n = 3) compared to the respective control clone.neither full-length GULP nor the GULP-PTB domain
affected the rate or magnitude of GTP bound to Arf6,
suggesting no direct effect of GULP on GTP loading of
Arf6 (Figure S2).
Another mechanism by which GULP could positively
influence Arf6-GTP level in cells might be through its
association with guanine-nucleotide exchange factors
(GEFs) for Arf6. However, we failed to detect an interac-
tion of GULP either with ARNO or EFA6, two known Arf6-
specific GEFs [19, 20] (Figure 2A). Because GULP itself
did not promote GTP loading of Arf6 and did not appear
to bind an Arf6-GEF, we considered whether GULP might
bind an Arf6-GAP; in such a case, through negative reg-
ulation of the Arf-GAP activity, GULP could indirectly in-
crease Arf6-GTP level. When we tested several known
GAPs, GULP specifically bound ACAP1, but not other
Arf6-GAPs such as ACAP2, Git1, or Git2 (Figure 2A).
We then tested whether GULP and ACAP1 could form
a complex at endogenous levels of expression. Endoge-
nous ACAP1 was coprecipitated with endogenous GULPfrom MEF-1 cells, but not from cells in which GULP was
depleted by RNAi (Figure 2B). To further test whether
GULP and ACAP1 bind directly, we expressed a His-
tagged ACAP1 fragment encoding amino acids 264–
741 in bacteria. This ACAP1 fragment associated with
bacterially produced GULP (Figure 2C, lane 3), suggest-
ing a direct interaction between these two proteins.
We then asked whether the GULP:ACAP1 interaction
influences Arf6-GTP level in cells. For this, we used
parental LR73 cells or LR73 cells stably expressing
full-length GULP (denoted GULP-FL). Expression of
GULP-FL enhanced Arf6-GTP level by 2-fold relative to
parental cells (Figure 2D, lane 3), as seen previously
(Figure 1F). To test the effect of ACAP1 in regulating
Arf6-GTP and how this might be regulated by GULP,
we transfected ACAP1 into different LR73 cell lines.
Overexpression of ACAP1 in parental LR73 cells
strongly reduced the basal level of Arf6-GTP. However,
this effect of ACAP1 was partially reversed by overex-
pressing the GULP-FL (Figure 2D, compare lanes 2
Current Biology
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ACAP1 and Reverses ACAP1-Mediated
Downregulation of Arf6-GTP Level in Cells
(A) GULP binds specifically to ACAP1 but
not other Arf6-GAPs or Arf6-GEFs. Epitope-
tagged versions of Arf6-GEFs or the Arf6-
GAPs were expressed in HeLa cells and
precipitated with bacterial GST-GULP or
GST alone, and the binding was assessed by
immunoblotting.
(B) Interaction between endogenous GULP
and ACAP1. Lysates from control or GULP-
knockdown MEF-1 cells were immunoprecip-
itated with anti-GULP and immunoblotted for
ACAP1. GULP knockdown and comparable
ACAP1 in total cell lysates were confirmed
by immunoblotting.
(C) GULP directly binds ACAP1 via the PTB
domain. Recombinant, bacterially produced
His-tagged ACAP1 fragment was incubated
with bacterially produced GST-GULP; GST-
GULP-PTB; GST alone; or an unrelated
protein, GST-RAP. The bound ACAP1 was
detected by anti-His immunoblotting.
(D) Partial reversal of the ACAP1-mediated
inhibition of endogenous Arf6-GTP by GULP
and GULP-PTB. Parental LR73 cells or LR73
cells stably expressing GST-tagged full-
length GULP or GULP-PTB domain were tran-
siently transfected with Flag-ACAP1 or empty
vector. The endogenous Arf6-GTP levels
were assessed as in Figure 1E.and 4). The effect of GULP on ACAP1 appeared to be
specific because coexpression of GULP with other
Arf-GAPs ACAP2 or AGAP1 did not affect cellular
Arf6-GTP level (Figure S3). Thus, GULP could counter
the effect of ACAP1 and thereby increase the level of
Arf6-GTP in cells.
GULP Reverses the ACAP1-Mediated Inhibition
of Cell Migration
We then tested a functional link between GULP and
ACAP1 in a cell-migration assay. Migration of HeLa cells
toward serum in a Boyden chamber assay was severely
inhibited by expression of ACAP1, and this inhibition
was dose dependent (Figure 3A, lanes 3, 5, and 7). Al-
though overexpression of GULP alone did not enhance
migration (lane 2), GULP coexpression partially reversed
the inhibition due to ACAP1 at all three doses of ACAP1
tested (Figure 3A, lanes 4, 6, and 8). The expression
levels of the transfected ACAP1 correlated with the
dose of plasmids cotransfected, and GULP was compa-
rably expressed in the different conditions (Figure 3A,
bottom panels).
We then assessed whether this effect of GULP on
ACAP1 was specific. Inhibition of cell migration by
ACAP2, another Arf6-GAP [3] that does not bind GULP,
was not affected by GULP coexpression (Figure 3B,
lanes 5 and 6). Moreover, overexpression of AGAP1, an
Arf1-specific GAP [21], did not significantly alter cell mi-
gration and was also not affected by coexpression of
GULP (Figure 3B, lanes 7 and 8). Moreover, the ability
of GULP to reverse the effect of ACAP1 was inhibited
by coexpression of a dominant-negative Arf6T27N (data
not shown).
We also tested the effect of GULP to reverse the
ACAP1-mediated inhibition of cell migration by usinga wound-healing assay. Overexpression of ACAP1
severely inhibited the ability of cells to fill the wound; co-
expression of GULP reversed the effect of ACAP1 and
restored wound closure to near control levels (Figure 3C,
compare lanes 3 and 4). This effect of ACAP1 was
dependent on its Arf6-GAP activity because a GAP-
deficient ACAP1 mutant did not affect migration and
coexpression of GULP did not alter wound closure (Fig-
ure 3C, lanes 5 and 6). Taken together, these data reveal
that GULP can functionally counter the effects of ACAP1
that rely on its GAP activity.
The PTB Domain of GULP Regulates ACAP1 via
Binding to Its GAP and Ankyrin Repeats
We then addressed the region of GULP required for
binding to ACAP1. Endogenous ACAP1 was precipi-
tated with the recombinant PTB domain of GULP, but
not the LZ+C region of GULP or a control protein, RAP
(Figure 4A). Thus, the PTB domain of GULP appeared
both necessary and sufficient for binding to ACAP1.
We then examined which region(s) of ACAP1 was re-
quired for GULP binding. ACAP1 possesses sequentially
a BAR domain, a PH domain, an Arf-GAP domain, and
a set of Ankyrin repeats (Figure 4B). We generated plas-
mid constructs encoding the various domains of ACAP1.
When the binding of the individual domains was as-
sessed, we found that a construct encoding both the
GAP domain and Ankyrin repeats of ACAP1 bound to
both GULP-FL and the PTB domain (Figure 4C). Given
that neither the isolated GAP domain nor the Ankyrin
repeats detectably bound GULP, it is possible that
GULP might bind both domains simultaneously, or the
Ankyrin repeats might confer on the GAP domain
a conformation that favors its binding to GULP. In fact,
previous crystal-structure studies of other Arf-GAPs
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Migration
(A) Reversal of ACAP1-mediated inhibition of cellular migration by
GULP is dose dependent. HeLa cells were cotransfected with a
GULP plasmid and decreasing amounts of ACAP1 plasmid. A con-
trol GFP-expressing plasmid was included in all of the transfections.
The migration of cells in a Transwell assay toward 20% FBS was
assessed. Results were standardized against the condition in which
only GFP and a control plasmid were transfected. Expression of
transfected ACAP1 and GULP, as well as the GFP and ERK2 levels
(to ensure equal loading of cells into the upper chamber of therevealed extensive interface between the GAP domain
and Ankyrin repeats [22]. Similarly, bacterially produced
GULP-PTB was also able to bind bacterially produced
fragments of ACAP1 containing the GAP+Ankyrin re-
peats (Figure 2C, lane 4), although this interaction was
less efficient than binding of ACAP1 from mammalian
cells. Notably, GULP-FL and the GULP-PTB bound com-
parably to both wild-type ACAP1 and the GAP-deficient
mutant of ACAP1 (ACAP1-GD) (Figure 4C), suggesting
that GAP activity is not a requirement for binding of
GULP to ACAP1.
Because the PTB domain alone is necessary and
sufficient to bind the GAP+Ankyrin repeats of ACAP1,
we tested the effect of GULP-PTB on Arf6-GTP level in
LR73 cells. Stable expression of GULP-PTB resulted in
a 2.9-fold increase in Arf6-GTP compared to parental
LR73 cells (Figure 2D, lane 5). Moreover, the PTB domain
alone reversed the effect of ACAP1 and increased the
level of Arf6-GTP in these cells (Figure 2D, lane 6). Func-
tionally, the PTB domain of GULP was able to reverse the
cell-migration inhibition due to ACAP1; this effect was
comparable to that of full-length GULP (Figure 4D).
These data suggest that the PTB domain of GULP is
important for regulation of ACAP1 function in vivo.
Trimeric-Complex Formation among GULP,
ACAP1, and GDP-Arf6
The binding of both Arf6 and ACAP1 to the PTB domain
of GULP raised the possibility that Arf6 and ACAP1
might compete with each other for binding to GULP,
or, alternatively, all three proteins could be part of the
same complex. Using the purified bacterial versions of
GULP, ACAP1, and Arf6T27N, we tested the complex
formation by mixing all three proteins simultaneously,
or by sequential addition. We could detect a complex
among GULP, ACAP1, and Arf6T27N (Figures 4E and
4F). The GTP-bound Arf6Q67L had no effect on the
trimeric-complex formation. When we increased the
amount of ACAP1 added, the binding of Arf6T27N to
GULP was enhanced in a dose-dependent fashion
(Figure 4F). Moreover, the amount of ACAP1 binding to
GULP is significantly enhanced by initial formation of
a GULP:Arf6T27N complex (Figure 4E). Taken together,
these results suggest that the binding of ACAP1 or
Arf6 to GULP does not inhibit the binding of the other,
and that there is a cooperative effect in the formation
of the GULP:ACAP1:Arf6 complex.
We also tested the tripartite-complex formation by
sequential precipitations of FLAG-ACAP followed by
elution of the complex and reprecipitation with GULP;
this definitively demonstrated the formation of the
Transwell) was assessed by immunoblotting. Relative ACAP1 ex-
pression levels were compared after setting the ratio of the ACAP1
signal to GFP signal in lane 3 as 1.0. * p < 0.05 (unpaired t test,
mean 6 SEM, n = 3).
(B) GULP specifically regulates ACAP1 inhibition of cellular migra-
tion. HeLa cells were cotransfected with the indicated plasmids,
and cell migration was assessed as in Figure 3A. * p < 0.05 (unpaired
t test, mean 6 SEM, n = 3).
(C) GULP regulates ACAP1-mediated inhibition of wound healing.
HeLa cells cotransfected with a GULP plasmid and wild-type
ACAP1 or a GAP-deficient mutant (ACAP1-GD) were examined in
the wound-healing assay. * p < 0.05 (unpaired t test, mean 6 SEM,
n = 3).
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(A) GULP-PTB is necessary and sufficient for binding to ACAP1. GST-tagged GULP-PTB, GULP-LZ+C, or an unrelated protein, RAP, was incu-
bated with HeLa cell lysates, and the binding of endogenous ACAP1 was assessed by immunoblotting.
(B) Schematic diagrams of ACAP1 mutants with an N-terminal Flag tag.
(C) GULP binds to the GAP+Ankyrin repeats of ACAP1. Full-length ACAP1 or the mutants expressed in HeLa cells were tested for binding to
GULP or GULP-PTB. The GST-GULP proteins on the membranes were visualized by Ponceau S staining.
(D) GULP-PTB partially rescues ACAP1-mediated inhibition of cell migration. GST alone, GST-tagged GULP, or GULP-PTB was cotransfected
with ACAP1 into HeLa cells. Cell migration across the Transwell membrane was assessed as in Figure 3A. * indicates statistical significance
(unpaired t test, p < 0.05, mean 6 SEM, n = 4).
(E–G) Trimeric-complex formation among GULP, Arf6, and ACAP1. (E) Arf6 mutants were incubated with bacterially produced GST-GULP bound
to glutathione beads. Recombinant His-ACAP1 was then added and the bound ACAP1 assessed. Precipitated ACAP1 levels were compared
after setting the ACAP1 signal in the condition of GST-GULP+ACAP1 only as 1.0 (lane 1). (F) Indicated amounts of bacterially produced recombi-
nant Arf6T27N and increasing amount of His-ACAP1 proteins were mixed with bacterially produced GST-GULP bound to glutathione beads. Arf6
levels were compared after setting the Arf6 signal in the GST-GULP+Arf6T27N only as 1.0 (lane 1). (G) Trimeric-complex formation among GULP,
ACAP1, and Arf6 is shown. Flag-tagged ACAP1 was incubated with GST-GULP and Arf6T27N. After washing and elution with Flag peptide,
a second precipitation using glutathione beads was performed, and the ACAP1 and Arf6 proteins precipitated with GST-GULP were assessed
by immunoblotting.GULP:ACAP1:Arf6 complex (Figure 4G). Moreover,
when we coexpressed all three proteins in cells, the level
of GULP coprecipitated with ACAP1 was increased
3-fold in the presence of exogenous Arf6T27N (data not
shown). This result, together with the in vitro data using
the purified proteins, suggests that the complex forma-
tion among GULP:ACAP1:GDP-bound Arf6 could serve
as one mechanism by which GULP could sequester
ACAP1 and thereby regulate the function of ACAP1.
Although downregulating Arf6 signaling via Arf6-
GAPs is important for regulation of various Arf6-depen-
dent cellular processes [1, 5], how Arf6-GAPs are regu-
lated is not well understood. The data presented here
identify GULP as a novel regulator of the Arf6-GAP
ACAP1 at the endogenous level of these proteins, and
indicate that removal of this GULP-mediated regulation
of ACAP1 can adversely affect the cellular Arf6-GTP.
This, in turn, correlates with the effect of GULP in
countering ACAP1-mediated inhibition of cell migra-
tion. One possible interpretation of the binding data be-
tween GULP and ACAP1 is that the GULP PTB domainbinds to the GAP and Ankyrin repeats and inhibits GAP
activity. Our in vitro assays to test this possibility have
been inconclusive, either when we added recombinant
GULP to ACAP1 isolated from eukaryotic cells, or
when we added GULP to the bacterially produced frag-
ment of ACAP1 (data not shown). Because GULP can
clearly reverse the ACAP1-mediated decrease in en-
dogenous Arf6-GTP level in cells, it is possible that
the GULP regulation of ACAP1 function might be
more complex, or might require better in vitro reagents
that are yet to be developed. Nevertheless, the trimeric-
complex formation among GULP, ACAP1, and Arf6T27N
suggests that the sequestration of ACAP1 (as part of
a complex with GDP-bound Arf6) is one mechanism
for GULP-mediated regulation of ACAP1, although a
direct inhibition of ACAP1 GAP activity is still formally
possible.
A large class of PTB-domain-containing adaptors in-
cluding Dab1, Dab2, ARH, Numb, and GULP modulate
endocytosis of cell-surface receptors as well as intracel-
lular movement of lipids such as cholesterol [15]; yet,
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that also regulate endocytosis and trafficking has not
been explored. Our data provide the first evidence for
a biochemical and functional link between these two
classes of proteins. Although a short fragment of X11/
MINT PTB domain was part of the clone isolated in
a yeast two-hybrid screen with GTP-Arf3/4, this lacked
much of the PTB domain, and the interaction was
ascribed to the PDZ domains [23]. Although the PTB
domains were initially named for their binding to phos-
photyrosine-containing NPXY motifs, PTB domains can
bind other types of ligands [24, 25]. We have shown
that GULP-PTB can recognize nonphosphorylated
cXNPXY motifs [18]; however, the precise motifs recog-
nized by GULP for binding to ACAP1 and Arf6 are un-
clear. Moreover the ability of GULP to engage Arf6 and
ACAP1 simultaneously via its PTB domain suggests
a more complicated type of recognition that remains to
be established. However, given the large number of
PTB-domain-containing proteins that have been shown
to play a role in trafficking of receptors and their bound
cargos, our identification of the PTB-mediated associa-
tion of GULP with Arf6 and a key intracellular regulator
of Arf6 (ACAP1) has broad implications for multiple
cellular processes.
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figures and are available with this article online at: http://www.
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